Recruiting Thyroid Cancer Studies in Boston
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
This research is being done to evaluate the safety and efficacy of neoadjuvant lenvatinib on surgical outcomes of patients with invasive extrathyroidal differentiated thyroid cancer (DTC). This resea...
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people with RET fusion-positive radioiodine-ref...
About Thyroid Cancer Clinical Trials in Boston
Thyroid cancer develops in the thyroid gland and is the most common endocrine malignancy. Most thyroid cancers are highly treatable with excellent prognosis. Types include papillary, follicular, medullary, and anaplastic thyroid cancer.
There are currently 2 thyroid cancer clinical trials recruiting participants in Boston, MASSACHUSETTS. These studies are seeking a combined 60 participants. Research is being sponsored by Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thyroid Cancer Clinical Trials in Boston — FAQ
Are there thyroid cancer clinical trials in Boston?
Yes, there are 2 thyroid cancer clinical trials currently recruiting in Boston, MASSACHUSETTS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What thyroid cancer treatments are being tested?
The 2 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for thyroid cancer.
Data updated March 2, 2026 from ClinicalTrials.gov